Generic and biosimilar medicines are saving families money and holding down government costs. The Association for Accessible Medicines (AAM), formerly known as the Generic Pharmaceutical Association, advocates for policies that ensure real competition not half-measures or window dressing. When we stop some brand drug companies from blocking or delaying competition from safe, effective and more affordable alternatives, patients and our healthcare system win.
